What one share of Instil Bio holds
In January 2026 we announced our wholly owned subsidiary, Axion Bio, Inc., or Axion Bio, was discontinuing development of our former lead product candidate, AXN-2510, a bispecific antibody targeting both programmed death-ligand 1 and the family of vascular endothelial growth factors in solid tumor cancers.
Instil Bio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.32 |
|---|---|
| Profit | −$4.47 |
| Cash and investments | $0.82 |
| Book value | $15.83 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.17 | −$47.18 | $63.53 | −$100.55 | — | −$38.46 |
| 2021 | $0.00 | −$29.59 | $10.91 | −$33.96 | — | $86.06 |
| 2022 | — | −$34.46 | $13.06 | −$40.88 | — | $55.91 |
| 2023 | $0.00 | −$24.00 | $3.18 | −$15.79 | — | $34.72 |
| 2024 | $0.66 | −$11.39 | $0.00 | −$8.56 | — | $25.96 |
| 2025 | $1.34 | −$10.70 | — | — | — | $16.79 |
Common questions about Instil Bio
How much does one share of Instil Bio earn?
Over the last 12 months, Instil Bio lost $4.47 for each share on $1.32 of sales.
Does Instil Bio pay a dividend?
Instil Bio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Instil Bio’s book value per share?
Instil Bio’s book value is $15.83 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Instil Bio have?
Each share of Instil Bio has $0.82 of cash and investments, as of June 30, 2026.
Has Instil Bio bought back shares?
Instil Bio’s share count rose about 734% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.